Novartis to make U.S. researchers' COVID-19 gene therapy vaccine hopeful

By John Miller ZURICH (Reuters) - Novartis re-entered vaccine making on Thursday, inking a manufacturing deal with a U.S.

Reuters May 29, 2020 00:12:57 IST
Novartis to make U.S. researchers' COVID-19 gene therapy vaccine hopeful

Novartis to make US researchers COVID19 gene therapy vaccine hopeful

By John Miller

ZURICH (Reuters) - Novartis re-entered vaccine making on Thursday, inking a manufacturing deal with a U.S. team whose COVID-19 candidate relies on technology similar to that of the Swiss drugmaker's $2.1 million-per-patient gene therapy, Zolgensma.

Human trials are planned this year, said Massachusetts General Hospital and Massachusetts Eye and Ear, which are behind the early stage project, adding vaccine manufacturing at Novartis's AveXis gene therapy unit will start before Monday.

The U.S. researchers aim to insert genetic material that makes up the new coronavirus's "spikes" into a so-called adeno-associated virus (AAV), before injecting it into humans to provoke an immune response against COVID-19.

Zolgensma, developed by AveXis for deadly spinal muscular atrophy, works similarly, delivering a copy of a missing gene packed inside AAV to babies whose muscles would otherwise not develop.

While Novartis divested its vaccines business to GlaxoSmithKline in 2015, AveXis President David Lennon said his unit's gene therapy expertise made it a good fit to join the Massachusetts' effort, a major departure from traditional vaccine making.

"When we evaluated the science of it, we were really enthusiastic," Lennon told Reuters. "And we believe we're one of the few companies that actually could provide the product in the time frame...given the urgency of the COVID-19 pandemic."

AveXis will donate technology and supply chain resources to making vaccine for early trials, while retaining future production options, if all goes well, Lennon said.

"We are at the scale of being able to do millions of doses," he said. "Obviously, we can tap into production in other parts of the industry."

The effort will not sap any production capacity from Zolgensma, he added.

Harvard Medical School professor Luk Vandenberghe, who initiated this vaccine candidate in his lab at Massachusetts Eye and Ear, said AveXis's commercial gene therapy experience made it the logical partner.

“We are more on track than ever to reaching our goal of developing a vaccine capable for wide distribution," Vandenberghe said in a statement announcing the deal.

(Reporting by John Miller; Editing by Lisa Shumaker)

This story has not been edited by Firstpost staff and is generated by auto-feed.

Updated Date:

TAGS:

also read

France, Germany to agree to NATO role against Islamic State - sources
| Reuters
World

France, Germany to agree to NATO role against Islamic State - sources | Reuters

By Robin Emmott and John Irish | BRUSSELS/PARIS BRUSSELS/PARIS France and Germany will agree to a U.S. plan for NATO to take a bigger role in the fight against Islamic militants at a meeting with President Donald Trump on Thursday, but insist the move is purely symbolic, four senior European diplomats said.The decision to allow the North Atlantic Treaty Organization to join the coalition against Islamic State in Syria and Iraq follows weeks of pressure on the two allies, who are wary of NATO confronting Russia in Syria and of alienating Arab countries who see NATO as pushing a pro-Western agenda."NATO as an institution will join the coalition," said one senior diplomat involved in the discussions. "The question is whether this just a symbolic gesture to the United States

China's Xi says navy should become world class
| Reuters
World

China's Xi says navy should become world class | Reuters

BEIJING Chinese President Xi Jinping on Wednesday called for greater efforts to make the country's navy a world class one, strong in operations on, below and above the surface, as it steps up its ability to project power far from its shores.China's navy has taken an increasingly prominent role in recent months, with a rising star admiral taking command, its first aircraft carrier sailing around self-ruled Taiwan and a new aircraft carrier launched last month.With President Donald Trump promising a US shipbuilding spree and unnerving Beijing with his unpredictable approach on hot button issues including Taiwan and the South and East China Seas, China is pushing to narrow the gap with the U.S. Navy.Inspecting navy headquarters, Xi said the navy should "aim for the top ranks in the world", the Defence Ministry said in a statement about his visit."Building a strong and modern navy is an important mark of a top ranking global military," the ministry paraphrased Xi as saying.